• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov26
Glaukos Corporation CFO Reports Sale of Common Stock
22:01
Nov21
Glaukos President and COO Disposes of Company Common Stock
00:56
Nov13
Piper Sandler Maintains Buy Rating on Glaukos
11:52
Nov10
Glaukos Corporation Unveils Growth Strategy for Eye Disease Treatments
12:17
Nov6
Brown Capital Management Reduces Holdings in Glaukos Corporation
12:08
Oct31
Glaukos Develops and Approves Epioxa
14:16

Schedules & Filings

Schedules
Filings
Oct29
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 133.54 M, Net Income -16.23 M, EPS -0.2827

Jul30
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 124.12 M, Net Income -19.66 M, EPS -0.3436

Apr30
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 106.66 M, Net Income -18.15 M, EPS -0.3203

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More